| |
|
|
Please note all CSES working papers series will be integrated
and consecutively numbered into a single series from 2008.
| |
|
CSES Working Papers 2007-2008
| No. 40 |
|
Returns to Training and Skill
Mismatch: Evidence from Australia
George Messinis and Nilss Olekalns, August 2008
|
| No. 39 |
The Role of Exports, FDI and Imports
in Development: New Evidence from Sub-Saharan African Countries
Abdullahi D. Ahmed, Enjiang Cheng and George Messinis, May 2008
|
| No. 38 |
Valuable Skills, Human Capital and
Technology Diffusion
George Messinis and Abdullahi D. Ahmed, April 2008
|
| No. 37 |
Overeducation and Overskilling in
Australia: Second Generation Greek-Australians and
Italian-Australians
George Messinis, March 2008
|
| No. 36 |
The Value of Education and Job
Training in the Developing World: New Evidence from Migrant Workers
in China
George Messinis and Enjiang Cheng, September 2007
|
| No. 35 |
Causal Links between Export, FDI and
Output: Evidence from Sub-Saharan African Countries
Ahmed Abdullahi, Enjiang Cheng and George Messinis, December 2007
|
| No. 34 |
The Other Side of Precariousness:
The Cost of Job Loss
Sally Weller, December 2007
|
| No. 33 |
Beyond “Global Production Networks”:
Australian Fashion Week’s Trans-sectoral Synergies
Sally Weller, October 2007 |
| |
|
| No. 32 |
Are Labour Markets Necessarily
‘Local’? Spatiality, Segmentation and Scale
Sally Weller, June 2007 |
| |
|
| No. 31 |
Discrimination, Labour Markets and
the Labour Market Prospects of Older Workers: What Can a Legal Case
Teach Us?
Sally Weller, December 2006 |
| |
|
| No. 30 |
Regulating Clothing Outwork: A
Sceptic’s View
Sally Weller, May 2005 |
| |
|
| No. 29 |
Retailing, Clothing and Textiles Production in Australia
Sally Weller, October 2007 |
| |
|
| No. 28 |
Power and Scale: The Shifting Geography of Industrial Relations Law
in Australia
Sally Weller, October 2007 |
| |
|
| No. 27 |
Beyond “Global Production Networks”: Australian Fashion Week’s
Trans-sectoral Synergies (see Paper 33)
Sally Weller, July 2007 |
| |
|
CSES Climate Change Working Papers
2004-2007
| No. 14 |
|
The New Global Growth Path: Implications for Climate Change Analysis
and Policy
Peter Sheehan, 2007 |
| |
|
| No. 13 |
Energy Use in China: Interpreting Changing Trends
and Future Directions
Peter Sheehan and Fiona Sun, 2007 |
| |
|
| No. 12 |
Climate Change and the New World Economy: Implications for the
Nature and Timing of Policy Responses (revised version of Working
Paper No. 11)
Peter Sheehan, Roger N. Jones, Ainsley Jolley, Benjamin L. Preston,
Matthew Clark, Paul J. Durack, Sardar Islam, Fiona Sun and Penny H.
Whetton, 2007 |
| |
|
| No. 11 |
Climate Change and the Global Knowledge Economy: An Immediate
Challenge
Peter Sheehan, Roger N. Jones, Ainsley Jolley, Benjamin L. Preston,
Matthew Clark, Paul J. Durack, Sardar Islam, Fiona Sun and Penny H.
Whetton, 2006 |
| |
|
| No. 10 |
Technologies for Reducing Non-Energy Related
Emissions
Ainsley Jolley, 2006 |
| |
|
| No. 9 |
The Supply of Fossil Fuels
Ainsley Jolley, 2006 |
| |
|
| No. 8 |
Advanced Technologies Applicable to Fossil Fuels:
Cross-cutting Technologies and Carbon Capture/Storage
Ainsley Jolley, 2006 |
| |
|
| No. 7 |
Technologies for Alternative Energy
Ainsley Jolley,
2006 |
| |
|
| No. 6 |
Technologies for Reducing Stationary Energy Use
Ainsley Jolley, 2006 |
| |
|
| No. 5 |
Transport Technologies
Ainsley Jolley, 2006 |
| |
|
| No. 4 |
Energy Use and Emissions in China
Peter Sheehan
and Fiona Sun, 2006 |
| |
|
| No. 3 |
New Technologies, Industry Developments and Emission Trends in Key Sectors: The Energy Sector
Ainsley Jolley, 2004 |
| |
|
| No. 2 |
New Technologies, Industry Developments and Emission Trends in Key Sectors: The Agricultural Sector
Ainsley Jolley, 2004 |
| |
|
| No. 1 |
New Technologies, Industry Developments and Emission Trends in Key Sectors: The Land Transportation Sector
Ainsley Jolley, 2004 |
| |
|
CSES Pharmaceutical Industry
Working Papers 2002-2007
| No. 37 |
|
Trends in Biopharmaceutical Alliances for the Key Business Models
Bruce Rasmussen, December 2007
|
| No. 36 |
Trends and Outcomes in the Australian Pharmaceutical Benefits Scheme
Kim Sweeny, December 2007
|
| No. 35 |
Key Aspects of the Australian Pharmaceutical Benefits Scheme
Kim Sweeny, November 2007
|
| No. 34 |
The Pharmaceutical Industry in Australia
Kim Sweeny, September 2007
|
| No. 33 |
Response of Pharmaceutical Companies to Biotechnology: Structure and
Business Models
Bruce Rasmussen, August 2007
|
| No. 32 |
Business Models and the Theory of the Firm
Bruce Rasmussen, June 2007
|
| No. 31 |
Open Innovation and the Networked Firm
Bruce Rasmussen, May 2007
|
| No. 30 |
Is Europe a
laggard in pharmaceuticals? R&D joint ventures, patent quality and
R&D productivity
George Messinis, September 2005 |
| |
|
| No. 29 |
Medicine prices in
Australia: An international comparison
Kim Sweeny, September 2005 |
| |
|
| No. 28 |
Accounting for
growth in the Pharmaceutical Benefits Scheme (superseded by PIP
Working Papers No. 34 to 36 – see above)
Kim Sweeny, September
2005 |
| |
|
| No.27 |
Patent
Quality
and R&D Productivity in Pharmaceuticals: The Role of Inflation and
International Collaboration’
George Messinis, August 2005 |
| |
|
| No. 26 |
Cost benefit
analysis of the PBS program: A new approach
Christine Mak and
Sardar Islam, May 2005 |
| |
|
| No. 25 |
A new framework
for cost benefit analysis of the health programs: A social choice
approach
Christine Mak and Sardar Islam, April 2005 |
| |
|
| No. 24 |
Developing the Biomedical Industries in Canada and Australia: An
Innovation Systems Approach
Bruce Rasmussen, February 2005 |
| |
|
| No. 23 |
Alliance Opportunities for Aus Biotech
Bruce Rasmussen, April 2004 |
| |
|
| No. 22 |
The Biomedical Sectors in Australia and Canada: Comparative Policy Analysis,
Bruce Rasmussen, July 2004 |
| |
|
| No. 21 |
An Analysis of the Biomedical Sectors in Australia and Canada in a National Innovation Systems Context
Bruce Rasmussen, July 2004 |
| |
|
| No. 20 |
The Biomedical Sectors in Australia and Canada: A Comparative Analysis
Bruce Rasmussen, May 2004 |
| |
|
| No. 19 |
Review of Findings: Australian Pharmaceutical Pricing in a Global Context
(superseded by PIP Working Paper No. 29 – see above)
Kim Sweeny, April 2004 |
| |
|
| No. 18 |
R&D Price Inflation, Real BERD and Innovation: Pharmaceuticals, OECD 1980-2000
George Messinis, May 2004 |
| |
|
| No. 17 |
Innovation and Industry Structure in the Biomedical Industry: Some Preliminary Results
Bruce Rasmussen, February 2004 |
| |
|
| No. 16 |
Australian Pharmaceutical Pricing in a Global Context: Trends and Issues
Kim Sweeny, February 2004 |
| |
|
| No. 15 |
Aspects of the Pharmaceutical Business Model: Implications for Australia
Bruce Rasmussen, August 2003 |
| |
|
| No. 14 |
Price and Quantity Trends in the Pharmaceutical Benefits Scheme
Kim Sweeny, August 2003 |
| |
|
| No. 13 |
Pharmaceuticals, Health and Industry Development: Strategic Issues and Options,
Peter Sheehan, August 2002 |
| |
|
| No. 12 |
Competition and Drug Pricing in the PBS: An Economic Interpretation
Peter Sheehan and Kim Sweeny, August 2002 |
| |
|
| No. 11 |
Demand and Price Dynamics in International Market: Some Preliminary Results
Kim Sweeny, August 2002 |
| |
|
| No. 10 |
Generic Drugs: International Trends and Policy Developments in Australia
Hans Lofgren, August 2002 |
| |
|
| No. 9 |
Health Costs, Innovation and Ageing
Peter Sheehan, August 2002 |
| |
|
| No. 8 |
Development Paths for Australian Biomedical Firms
Bruce Rasmussen and
Kim Sweeny, September 2002 |
| |
|
| No. 7 |
The Australian Pharmaceutical Industry and Its Global Context
George Messinis,
September 2002 |
| |
|
| No. 6 |
Demand and Price Dynamics within the Pharmaceutical Benefits Scheme
Kim Sweeny,
June 2002 |
| |
|
| No. 5 |
Trends in the Use and Cost of Pharmaceuticals under the Pharmaceutical Benefits Scheme
Kim Sweeny, June 2002 |
| |
|
| No. 4 |
Information Technology and the Revolution in Healthcare
John Houghton, June 2002 |
| |
|
| No. 3 |
Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia
Kim Sweeny, March 2002 |
| |
|
| No. 2 |
The Role of Pharmaceutical Alliances
Bruce Rasmussen, June 2002 |
| |
|
| No. 1 |
Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia
Bruce Rasmussen, March 2002 |
| |
|
|
CSES Working Papers 1995-2006 | |
|
| | |
|
| | |
|
|
